Select Publications
Conference Papers
2005, 'Epithelial-stromal interactions in pancreatic cancer: do pancreatic cancer cells actively recruit host stromal cells for their own benefit?', in The Peter McCallum Institute (ed.), 6th Peter MacCallum Cancer Symposium, Molecular and Cell Biology of Cancer, Melbourne, pp. 21 - 21, presented at 6th Peter MacCallum Cancer Symposium, Molecular and Cell Biology of Cancer, Melbourne, 14 November 2005 - 16 November 2005
,2005, 'Does chronic ethanol administration sensitise rat pancreatic stellate cells to proinflammatory cytokynes?', in Gastroenterology, W B Saunders Co, Philadelphia, PA, USA, pp. A378 - A378, presented at Digestive Disease Week and the 106th Annual Meeting of the American Gastroenterological Association, Chicago Illinois USA, 14 May 2005 - 19 May 2005
,2004, 'Cholecystokinin activates intracellular signalling pathways in pancreatic stellate cells', in Pancreas, Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp. 479 - 480, presented at 36th Annual Meeting of the American Pancreatic Association, Chicago Illinois USA, 03 November 2004 - 04 November 2004
,2003, 'Oxidant stress induces the p38 mitogen activated protein kinase (p38 MAPK) signalling pathway in pancreatic stellate cells', in GASTROENTEROLOGY, W B SAUNDERS CO, FLORIDA, ORLANDO, pp. A616 - A616, presented at Digestive Disease Week 2003 Meeting/104th Annual Meeting of the American-Gastroenterological-Association, FLORIDA, ORLANDO, 17 May 2003 - 22 May 2003, http://dx.doi.org/10.1016/S0016-5085(03)83119-0
,2002, 'Pancreatic stellate cell migration: Effect of basement membrane components and role of phosphatidylinositol 3 ' kinase (PI3 kinase) pathway', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A412 - A412, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000175366602088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2001, 'Pancreatic stellate cells are activated by tumour necrosis factor a (TNFa) - implications for pancreatic fibrogenesis', in Podolsky DK (ed.), Digestive Disease Week and the 101st Annual Meeting of the American Gastroenterological Association, San Diego, California, USA, pp. 118:A424, presented at Digestive Disease Week and the 101st Annual Meeting of the American Gastroenterological Association, San Diego, California, USA, -
,2000, 'Pancreatic stellate cells are activated by tumour necrosis factor A (TNFA) - Implications for pancreatic fibrogenesis', in Gastroenterology, WB Saunders, pp. A424 - A424, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000086783701737&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2000, 'Collagen synthesis by pancreatic stellate cells - response to inflammatory cytokines', in Digestion, Karger, Basel, Switzerland, pp. 61:A258, presented at Digestion
,1999, 'Alcohol causes pancreatic fibrosis via activation of pancreatic stellate cells: an in vitro study', in Lam SK (ed.), Annual meeting of Gastroenterological Society of Australia, pp. 14:A115, presented at Annual meeting of Gastroenterological Society of Australia
,1999, 'Role of pancreatic stellate cells in the pathogenesis of alcoholic pancreatic fibrosis', in Pancreas, Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp. 0.87083333, presented at Annual meeting of American Pancreatic Association Chicago USA 11.99
,Conference Abstracts
2018, 'Metabolically Reprograming Pancreatic Stellate Cells Using a Novel Nanomedicine for the Treatment of Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 47, pp. 1422 - 1422, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449304600230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'ROBO2 is a Stroma Suppressor Gene in the Pancreas Through Regulation of TGF-beta', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 47, pp. 1417 - 1417, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449304600212&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'beta III-Tubulin is a Brake for External Cell-Death Signaling and Regulates TRAIL Sensitivity in Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Miami Beach, Florida, Vol. 47, pp. 1401 - 1401, presented at 49th Annual Meeting of the American Pancreatic Association, Miami Beach, Florida, 31 October 2018 - 03 November 2018, http://dx.doi.org/10.1097/MPA.0000000000001177
,2018, 'Targeting a solute carrier to metabolically reprogram tumour-promoting stromal cells in pancreatic cancer', in Pancreatology, Elsevier BV, Vol. 18, pp. S156 - S156, http://dx.doi.org/10.1016/j.pan.2018.05.419
,2016, 'MutY-Homolog Modulates Pancreatic Cancer Cell Survival and Chemoresistance', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 45, pp. 1534 - 1534, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000386978400183&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'MutY-homolog modulates pancreatic cancer cell survival and chemoresistance', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, Vol. 31, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'beta III-Tubulin Regulates Sensitivity to Nab-Paclitaxel (Abraxane (R)) in Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 44, pp. 1414 - 1415, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363324000260&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'beta IVb-Tubulin is a Novel Therapeutic Target for the Treatment of Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 44, pp. 1414 - 1414, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363324000259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Pancreatic Human Fibroblast Expression Profiling Reveals Novel microRNAs and mRNAs in the Diseased Pancreas', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 44, pp. 1361 - 1362, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363324000043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Erratum: Effective Delivery of siRNA into Cancer Cells and Tumors Using Well-Defined Biodegradable Cationic Star Polymers (Molecular Pharmaceutics (2013) 10: 6 (2435−2444) DOI: 10.1021/mp400049e)', in Molecular Pharmaceutics, Vol. 12, pp. 1004, http://dx.doi.org/10.1021/acs.molpharmaceut.5b00092
,2012, 'Stathmin suppression influences ROCK signaling and reduces cell invasion and metastasis in neuroblastoma', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 72, http://dx.doi.org/10.1158/1538-7445.AM2012-1444
,2010, 'Beta III- and Beta IVB-Tubulin Mediate Sensitivity to Chemotherapeutic Drugs in Pancreatic Cancer Cells', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 39, pp. 1330 - 1330, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000282946600138&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Beta III- and beta IVb-tubulin mediate sensitivity to chemotherapeutic drugs in pancreatic cancer cells', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, Vol. 25, pp. A76 - A76, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Preprints
2022, βIII-Tubulin is a Brake on Extrinsic Cell-Death in Pancreatic Cancer, http://dx.doi.org/10.1101/2022.09.29.510034
,2020, Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to SLC7A11 inhibition, http://dx.doi.org/10.1101/2020.07.12.199638
,Other
2023, Data from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, http://dx.doi.org/10.1158/0008-5472.c.6512931.v1
,2023, Data from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, http://dx.doi.org/10.1158/0008-5472.c.6512931
,2023, Figure S1 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, http://dx.doi.org/10.1158/0008-5472.22428180.v1
,2023, Figure S1 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, http://dx.doi.org/10.1158/0008-5472.22428180
,2023, Figure S2 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, http://dx.doi.org/10.1158/0008-5472.22428177.v1
,2023, Figure S2 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, http://dx.doi.org/10.1158/0008-5472.22428177
,2023, Figure S3 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, http://dx.doi.org/10.1158/0008-5472.22428168.v1
,2023, Figure S3 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, http://dx.doi.org/10.1158/0008-5472.22428168
,2023, Figure S4 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, http://dx.doi.org/10.1158/0008-5472.22428165.v1
,2023, Figure S4 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, http://dx.doi.org/10.1158/0008-5472.22428165
,2023, Supplementary Table 1 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, http://dx.doi.org/10.1158/0008-5472.22428162
,2023, Supplementary Table 1 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, http://dx.doi.org/10.1158/0008-5472.22428162.v1
,2023, Supplementary Table 2 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, http://dx.doi.org/10.1158/0008-5472.22428159.v1
,2023, Supplementary Table 2 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, http://dx.doi.org/10.1158/0008-5472.22428159
,2023, Supplementary Table 3 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, http://dx.doi.org/10.1158/0008-5472.22428156.v1
,2023, Supplementary Table 3 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, http://dx.doi.org/10.1158/0008-5472.22428156
,2023, Supplementary Table 4 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, http://dx.doi.org/10.1158/0008-5472.22428153.v1
,2023, Supplementary Table 4 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, http://dx.doi.org/10.1158/0008-5472.22428153
,